000			01977 a2200565 4500
005			20250513083155.0
264		0	_c19960125
008			199601s 0 0 eng d
022			_a0171-2985
024	7		_a10.1016/s0171-2985(11)80429-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aShinomiya, Y
245	0	0	_aAnti-metastatic activity induced by the in vivo activation of purified protein derivative (PPD)-recognizing Th1 type CD4+ T cells. _h[electronic resource]
260			_bImmunobiology _cAug 1995
300			_a439-55 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aAscitic Fluid _ximmunology
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aClone Cells _ximmunology
650	0	4	_aCytotoxicity Tests, Immunologic
650	0	4	_aDose-Response Relationship, Immunologic
650	0	4	_aFemale
650	0	4	_aImmunotherapy, Adoptive
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aInterferon-gamma _xadministration & dosage
650	0	4	_aKiller Cells, Natural _xdrug effects
650	0	4	_aLung Neoplasms _ximmunology
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aLymphoma _ximmunology
650	0	4	_aMast-Cell Sarcoma
650	0	4	_aMelanoma, Experimental _ximmunology
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C3H
650	0	4	_aMice, Inbred C57BL
650	0	4	_aTh1 Cells _xdrug effects
650	0	4	_aTuberculin _xadministration & dosage
650	0	4	_aTumor Cells, Cultured
700	1		_aHarada, M
700	1		_aKurosawa, S
700	1		_aOkamoto, T
700	1		_aTerao, H
700	1		_aMatsuzaki, G
700	1		_aShirakusa, T
700	1		_aNomoto, K
773	0		_tImmunobiology _gvol. 193 _gno. 5 _gp. 439-55
856	4	0	_uhttps://doi.org/10.1016/s0171-2985(11)80429-8 _zAvailable from publisher's website
999			_c8521613 _d8521613